688189 南新製藥
按盤價 
7.660 +0.190 (+2.544%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -5.625 | 0.285 | -5.823 | -10.832 | 13.272 |
| 總資產報酬率 ROA (%) | -4.625 | 0.203 | -3.859 | -7.678 | 8.811 |
| 投入資產回報率 ROIC (%) | -4.832 | 0.212 | -4.094 | -8.237 | 9.739 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.368 | 84.725 | 85.788 | 87.125 | 89.809 |
| 營業利潤率 (%) | -36.880 | 0.995 | -10.512 | -28.852 | 12.819 |
| 息稅前利潤/營業總收入 (%) | -36.893 | 1.692 | -9.810 | -28.734 | 13.631 |
| 淨利潤/營業總收入 (%) | -36.488 | 0.800 | -13.968 | -24.539 | 13.047 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -10.368 | 1,530.576 | -52.660 | 46.545 | 109.703 |
| 價值變動淨收益/利潤總額(%) | 0.000 | -196.019 | 7.610 | -1.551 | 6.108 |
| 營業外收支淨額/利潤總額(%) | -0.897 | 2.564 | 0.739 | 0.105 | 1.840 | 償債能力分析 |
| 流動比率 (X) | 5.926 | 3.004 | 2.308 | 2.391 | 4.489 |
| 速動比率 (X) | 5.490 | 2.938 | 2.266 | 2.300 | 4.350 |
| 資產負債率 (%) | 11.611 | 25.048 | 33.676 | 34.582 | 22.381 |
| 帶息債務/全部投入資本 (%) | 5.628 | 20.139 | 29.321 | 28.971 | 17.823 |
| 股東權益/帶息債務 (%) | 1,669.765 | 394.832 | 239.254 | 243.183 | 458.485 |
| 股東權益/負債合計 (%) | 778.002 | 302.869 | 199.680 | 189.065 | 341.814 |
| 利息保障倍數 (X) | 108.068 | 2.524 | -12.573 | -194.419 | 23.824 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 579.087 | 307.531 | 339.743 | 297.907 | 155.041 |
| 存貨周轉天數 (天) | 133.430 | 87.724 | 160.282 | 215.745 | 148.334 |
| 備註： | 即時報價更新時間為 20/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
